top of page
OBJECTIVE: To evaluate whether myo-inositol supplementation may reduce gestational diabetes mellitus (GDM) rate in overweight women. METHODS: In an open-label, randomized trial, myo-inositol (2 g plus 200 μg folic acid twice a day) or placebo (200 μg folic acid twice a day) was administered from the first trimester to delivery in pregnant overweight non-obese women (pre-pregnancy body mass index ≥ 25 and
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial.
Santamaria A et al., 2015
Santamaria A, Petrella E, Pintaudi B, Corrado F, D'Anna R, Neri I, Facchinetti F, Di Benedetto A
bottom of page